Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants
Bovine viral diarrhea virus (BVDV) is considered an important cause of economic loss within bovine herds worldwide. In Argentina, only the use of inactivated vaccines is allowed, however, the efficacy of inactivated BVDV vaccines is variable due to its low immunogenicity. The use of recombinant subunit vaccines has been proposed as an alternative to overcome this difficulty. Different studies on protection against BVDV infection have focused the E2 protein, supporting its putative use in subunit vaccines. Utilization of transgenic plants expressing recombinant antigens for the formulation of experimental vaccines represents an innovative and cost effective alternative to the classical fermentation systems. The aim of this work was to develop transgenic alfalfa plants (Medicago sativa, L.) expressing a truncated version of the structural protein E2 from BVDV fused to a molecule named APCH, that target to antigen presenting cells (APCH-tE2). The concentration of recombinant APCH-tE2 in alfalfa leaves was 1 μg/g at fresh weight and its expression remained stable after vegetative propagation. A methodology based an aqueous two phases system was standardized for concentration and partial purification of APCH-tE2 from alfalfa. Guinea pigs parentally immunized with leaf extracts developed high titers of neutralizing antibodies. In bovine, the APCH-tE2 subunit vaccine was able to induce BVDV-specific neutralizing antibodies. After challenge, bovines inoculated with 3 μg of APCH-tE2 produced in alfalfa transgenic plants showed complete virological protection. © 2012.
Main Authors: | , , , , , , , , , , |
---|---|
Format: | journal article biblioteca |
Language: | English |
Published: |
Elsevier
2013
|
Subjects: | Transgenic plants, Bovine viral diarrhea virus, Subunit vaccine, |
Online Access: | http://hdl.handle.net/20.500.12792/3388 http://hdl.handle.net/10261/294319 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
dig-inia-es-10261-294319 |
---|---|
record_format |
koha |
spelling |
dig-inia-es-10261-2943192023-02-20T10:37:35Z Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants Pérez Aguirreburualde, M. S. Gómez, M. C. Ostachuk, A. Wolman, F. Albanesi, G. Pecora, A. Odeon, A. Ardila, F. Escribano, J. M. Dus Santos, M. J. Wigdorovitz, A. Transgenic plants Bovine viral diarrhea virus Subunit vaccine Bovine viral diarrhea virus (BVDV) is considered an important cause of economic loss within bovine herds worldwide. In Argentina, only the use of inactivated vaccines is allowed, however, the efficacy of inactivated BVDV vaccines is variable due to its low immunogenicity. The use of recombinant subunit vaccines has been proposed as an alternative to overcome this difficulty. Different studies on protection against BVDV infection have focused the E2 protein, supporting its putative use in subunit vaccines. Utilization of transgenic plants expressing recombinant antigens for the formulation of experimental vaccines represents an innovative and cost effective alternative to the classical fermentation systems. The aim of this work was to develop transgenic alfalfa plants (Medicago sativa, L.) expressing a truncated version of the structural protein E2 from BVDV fused to a molecule named APCH, that target to antigen presenting cells (APCH-tE2). The concentration of recombinant APCH-tE2 in alfalfa leaves was 1 μg/g at fresh weight and its expression remained stable after vegetative propagation. A methodology based an aqueous two phases system was standardized for concentration and partial purification of APCH-tE2 from alfalfa. Guinea pigs parentally immunized with leaf extracts developed high titers of neutralizing antibodies. In bovine, the APCH-tE2 subunit vaccine was able to induce BVDV-specific neutralizing antibodies. After challenge, bovines inoculated with 3 μg of APCH-tE2 produced in alfalfa transgenic plants showed complete virological protection. © 2012. 2023-02-20T10:37:35Z 2023-02-20T10:37:35Z 2013 journal article Veterinary Immunology and Immunopathology 151 (3-4): 315-324 (2013) 0165-2427 http://hdl.handle.net/20.500.12792/3388 http://hdl.handle.net/10261/294319 10.1016/j.vetimm.2012.12.004 en none Elsevier |
institution |
INIA ES |
collection |
DSpace |
country |
España |
countrycode |
ES |
component |
Bibliográfico |
access |
En linea |
databasecode |
dig-inia-es |
tag |
biblioteca |
region |
Europa del Sur |
libraryname |
Biblioteca del INIA España |
language |
English |
topic |
Transgenic plants Bovine viral diarrhea virus Subunit vaccine Transgenic plants Bovine viral diarrhea virus Subunit vaccine |
spellingShingle |
Transgenic plants Bovine viral diarrhea virus Subunit vaccine Transgenic plants Bovine viral diarrhea virus Subunit vaccine Pérez Aguirreburualde, M. S. Gómez, M. C. Ostachuk, A. Wolman, F. Albanesi, G. Pecora, A. Odeon, A. Ardila, F. Escribano, J. M. Dus Santos, M. J. Wigdorovitz, A. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
description |
Bovine viral diarrhea virus (BVDV) is considered an important cause of economic loss within bovine herds worldwide. In Argentina, only the use of inactivated vaccines is allowed, however, the efficacy of inactivated BVDV vaccines is variable due to its low immunogenicity. The use of recombinant subunit vaccines has been proposed as an alternative to overcome this difficulty. Different studies on protection against BVDV infection have focused the E2 protein, supporting its putative use in subunit vaccines. Utilization of transgenic plants expressing recombinant antigens for the formulation of experimental vaccines represents an innovative and cost effective alternative to the classical fermentation systems. The aim of this work was to develop transgenic alfalfa plants (Medicago sativa, L.) expressing a truncated version of the structural protein E2 from BVDV fused to a molecule named APCH, that target to antigen presenting cells (APCH-tE2). The concentration of recombinant APCH-tE2 in alfalfa leaves was 1 μg/g at fresh weight and its expression remained stable after vegetative propagation. A methodology based an aqueous two phases system was standardized for concentration and partial purification of APCH-tE2 from alfalfa. Guinea pigs parentally immunized with leaf extracts developed high titers of neutralizing antibodies. In bovine, the APCH-tE2 subunit vaccine was able to induce BVDV-specific neutralizing antibodies. After challenge, bovines inoculated with 3 μg of APCH-tE2 produced in alfalfa transgenic plants showed complete virological protection. © 2012. |
format |
journal article |
topic_facet |
Transgenic plants Bovine viral diarrhea virus Subunit vaccine |
author |
Pérez Aguirreburualde, M. S. Gómez, M. C. Ostachuk, A. Wolman, F. Albanesi, G. Pecora, A. Odeon, A. Ardila, F. Escribano, J. M. Dus Santos, M. J. Wigdorovitz, A. |
author_facet |
Pérez Aguirreburualde, M. S. Gómez, M. C. Ostachuk, A. Wolman, F. Albanesi, G. Pecora, A. Odeon, A. Ardila, F. Escribano, J. M. Dus Santos, M. J. Wigdorovitz, A. |
author_sort |
Pérez Aguirreburualde, M. S. |
title |
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
title_short |
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
title_full |
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
title_fullStr |
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
title_full_unstemmed |
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
title_sort |
efficacy of a bvdv subunit vaccine produced in alfalfa transgenic plants |
publisher |
Elsevier |
publishDate |
2013 |
url |
http://hdl.handle.net/20.500.12792/3388 http://hdl.handle.net/10261/294319 |
work_keys_str_mv |
AT perezaguirreburualdems efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT gomezmc efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT ostachuka efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT wolmanf efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT albanesig efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT pecoraa efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT odeona efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT ardilaf efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT escribanojm efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT dussantosmj efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants AT wigdorovitza efficacyofabvdvsubunitvaccineproducedinalfalfatransgenicplants |
_version_ |
1767603598102888448 |